0
Article Tier 2 Sign in to save

Effects of microplastics on the colorectal tumor immune microenvironment and immunotherapy resistance via JAK–STAT–microbiota perturbation.

Original title: Effects of microplastics on the colorectal tumor immune microenvironment and immunotherapy resistance via JAK–STAT–microbiota perturbation.

AI summary Read the abstract

Scientists found that microplastics—tiny plastic particles now common in our environment—can build up in colorectal (colon) tumors and make cancer immunotherapy less effective, based on studies in mice. The plastics seem to weaken the immune system's ability to find and attack cancer cells, partly by disrupting gut bacteria and blocking key immune signals. While this research was done in animals rather than people, it raises concerning questions about whether everyday plastic exposure could affect cancer treatment outcomes in humans.

Body Systems

e15731 Background: Microplastics (MPs) are pervasive environmental pollutants with rising human exposure. Although potential health effects have been recognized, their link to cancer remains poorly defined. The colorectum represents a primary absorption site for MPs, prompting investigation of their impact on colorectal cancer (CRC) progression and immunotherapy response. Methods: MPs were isolated and characterized from CRC tumor tissues and matched blood samples. Functional studies were conducted in murine CRC models to evaluate tumor progression, immune cell infiltration, gut microbiota alterations, and response to anti–PD-L1 therapy. Transcriptomic profiling and immune analyses were performed to elucidate underlying mechanisms. Results: MP exposure aggravated CRC progression and significantly reduced sensitivity to anti–PD-L1 therapy. Mechanistically, tumor-infiltrating MPs suppressed JAK-STAT signaling, downregulated IFN-γ, CXCL9, CXCL11, B2m, and H2-K1 expression, and reduced CD8⁺ and CD4⁺ T-cell infiltration, resulting in impaired antigen presentation and T-cell recruitment. MPs also induced gut microbiota dysbiosis that further contributed to immunotherapy resistance. Conclusions: MPs promote CRC immunotherapy resistance by altering the tumor immune microenvironment through disruption of the JAK-STAT–microbiota axis. These data highlight MPs as an unrecognized determinant of CRC immunotherapy outcomes and a potential modifiable environmental target amid rising global MP contamination.

More Papers Like This

Article Tier 2

Tumour-infiltrating microplastics disrupt the JAK-STAT-microbiota axis to promote immunotherapy resistance in colorectal cancer

AI summary Read the abstract

Researchers isolated microplastics from colorectal cancer tumor tissues and blood samples and examined their properties and effects on cancer progression. They found that tumor-infiltrating microplastics disrupted the JAK-STAT signaling pathway and altered gut microbiota composition, potentially reducing the effectiveness of immunotherapy. The study suggests that microplastic presence in tumors may be a factor worth investigating in cancer treatment outcomes.

Article Tier 2

Nanoplastics Shape Adaptive Anticancer Immunity in the Colon in Mice

AI summary Read the abstract

In a mouse study, researchers found that orally administered polyethylene nanoplastics disrupted the intestinal immune environment in ways that could favor tumor growth in the colon. The nanoplastics altered immune cell populations and promoted an immunosuppressive environment around colorectal tumors. The study suggests that nanoplastic exposure may influence how the immune system responds to abnormal cell growth in the gut.

Article Tier 2

A multi-omics signature of microplastic exposure and its clinical, metabolic, and microbial correlates in colorectal cancer

AI summary Read the abstract

Scientists found tiny plastic particles (from common plastics like PVC and polyethylene) built up more in colon tumors and the tissue around them than in blood samples from cancer patients. These plastic particles were linked to changes in blood chemistry and gut bacteria, suggesting microplastics might interact with the body's metabolism in ways connected to colorectal cancer. This is early evidence, not proof of cause and effect, but it highlights why reducing plastic exposure and further research into this link matter for gut health.

Article Tier 2

Effects of microplastics on chemo-resistance and tumorigenesis of colorectal cancer

AI summary Read the abstract

For the first time, researchers confirmed the presence of microplastics in human colorectal cancer tissue and showed in animal models that microplastics increased cancer rates and made tumors more resistant to chemotherapy drugs. The study found that microplastics trigger a cell survival mechanism called autophagy that helps cancer cells resist treatment, suggesting plastic pollution could complicate cancer outcomes.

Article Tier 2

Detection and quantification of microplastics in various types of human tumor tissues

AI summary Read the abstract

Researchers detected microplastics in 43% of tumor samples across lung, gastric, colorectal, cervical, and pancreatic cancers, with polystyrene, PVC, and polyethylene being the types found. In pancreatic tumors, microplastic presence was associated with fewer immune cells that fight cancer and more immune cells linked to tumor progression, suggesting microplastics may create conditions that help tumors evade the immune system.

Research digests by email

When a large batch of papers lands in the Atlas, we read through it and send a short write-up of what stood out.

Email me about

Share this paper